# EDGAR Filing Document

**Accession Number:** 0001163573
**File Stem:** 0001171843-26-002399
**Filing Date:** 2026-4
**Character Count:** 11067
**Document Hash:** 5cb36296f4e030d19f1cb48dfd5b73a9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001171843-26-002399.hdr.sgml**: 20260413

**ACCESSION NUMBER**: 0001171843-26-002399

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20251117

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260413

**DATE AS OF CHANGE**: 20260413

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ProText Mobility, Inc.
- **CENTRAL INDEX KEY:** 0001163573
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 113621755
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-31590
- **FILM NUMBER:** 26856881

**BUSINESS ADDRESS:**
- **STREET 1:** 55 SE 2ND AVE.
- **CITY:** DELRAY BEACH
- **STATE:** FL
- **ZIP:** 3344
- **BUSINESS PHONE:** 516-802-0223

**MAIL ADDRESS:**
- **STREET 1:** 55 SE 2ND AVE.
- **CITY:** DELRAY BEACH
- **STATE:** FL
- **ZIP:** 3344

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Echo Metrix, Inc.
- **DATE OF NAME CHANGE:** 20090617

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SEARCHHELP INC
- **DATE OF NAME CHANGE:** 20011213

?xml version='1.0' encoding='ASCII'? Form 8-K

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

### Washington, D.C. 20549
_________________

### FORM 8-K
_________________

#### CURRENT REPORT

#### Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

#### Date of Report (Date of earliest event reported): November 17, 2025
_______________________________

#### ProText Mobility, Inc.
(Exact name of registrant as specified in its charter)

_______________________________

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-31590** | **11-3621755** |
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |

---

#### One West Las Olas Blvd., Ste 500

#### Fort Lauderdale, Florida 33301
(Address of Principal Executive Offices) (Zip Code)

#### (+27) 72 889 2581
(Registrant's telephone number, including area code)

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| N/A | N/A | N/A |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 8.01. Other Events.**

Explanatory Note Regarding Voluntary Retroactive Filing

This Current Report on Form 8-K is being filed voluntarily by ProText Mobility, Inc. (OTC PINK: TXTM) (the "Company") pursuant to Item 8.01 of Form 8-K under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Company is a former SEC reporting company (CIK No. 0001163573, Commission File No. 001-31590) that is voluntarily submitting this and other Form 8-K filings to introduce into the public record on the SEC's EDGAR system certain press releases and corporate disclosures previously disseminated through the OTC Disclosure & News Service and other recognized news distribution channels. These voluntary filings are being made as part of the Company's ongoing efforts to enhance transparency, strengthen its public disclosure practices, and prepare for a potential uplisting to a national securities exchange. The press release attached hereto as Exhibit 99.1 was originally published and publicly disseminated on 11/17/2025. This Form 8-K is being filed on a retroactive, voluntary basis and the Company does not by this filing assume any obligation to file current reports under Section 13 or 15(d) of the Exchange Act beyond what may otherwise be required by applicable law.

Filing Status

The information contained in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being deemed "filed" for purposes of Section 18 of the Exchange Act and shall be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, to the extent not superseded by information contained in any such subsequent filing.

On 11/17/2025, the Company issued a press release announcing a strategic Letter of Intent with TruLeaf, involving technology synergies between TruLeaf's nanotechnology and the Company's kettle technology, initial product samples and inventory shipments, and plans for CBD-based asset tokenization as real-world assets. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

**Item 9.01. Financial Statements and Exhibits.**

**(d) Exhibits.**

---

| | |
|:---|:---|
| <u>Exhibit No.</u> | <u>Description</u> |
| [99.1](exh_991.htm) | [Press Release dated 11/17/2025 — Protext Mobility, Inc. Announces Strategic TruLeaf Partnership & Next-Level Innovation](exh_991.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **ProText Mobility, Inc.** | **ProText Mobility, Inc.** |
| Date: April 13, 2026 | By: | <u>/s/ Dylon Du Plooy&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> |
|  |  | Dylon Du Plooy |
|  |  | Chief Executive Officer |

---

## Exhibit 99.1

**EXHIBIT 99.1**

**Protext Mobility, Inc. (OTC: TXTM) Announces Strategic TruLeaf Partnership & Next-Level Innovation**

FORT LAUDERDALE, Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Protext Mobility, Inc. (OTC: TXTM) ("Protext" or the "Company") is proud to announce a strategic Letter of Intent (LOI) with TruLeaf, marking a pivotal moment in the company's growth and mission. This partnership not only accelerates technology adoption and market expansion but also opens the door to innovative financial applications leveraging CBD-based assets.

Highlights:

* TruLeaf provides strategic support, including product samples, initial inventory shipments, infrastructure support, and operational resources.

* Perfect synergy: TruLeaf's nanotechnology enhances TXTM's kettle technology, significantly increasing bioavailability. Products are cheaper, faster-acting, and more effective, benefiting patients worldwide.

* TruLeaf's natural CBD FECO without THC, combined with Farm Bill compliance, provides a regulatory and competitive advantage.

* The resulting API (active pharmaceutical ingredient) and mg quantities of CBD can be treated as real-world assets (RWA) on the company's balance sheet, recognized under IFRS/GAAP as income/gain, strengthening net profit without cash outflow.

* These assets could potentially support the creation of a stablecoin, enabling future staking, investment, or liquidity applications — a true financial innovation benefiting all shareholders.

* This partnership is aligned with TXTM Tribe Mission: raising all boats by improving patient outcomes, advancing global healing, and creating shareholder value.

Strategic Rationale

* Technological Synergy & Bioavailability TruLeaf's nanotechnology complements TXTM's kettle technology.Dramatically increases bioavailability, improving effectiveness and speed of action for patients.Reduces production costs, enhancing shareholder value.Supports the mission of global healing and patient wellbeing. 

* Regulatory & Competitive Advantage THC-free CBD FECO aligns with Farm Bill compliance.Provides a clear market differentiation and competitive edge. 

* Financial Strengthening & Asset Potential CBD API is a real-world asset (RWA) recognized under IFRS/GAAP as income/gain.Strengthens balance sheet, net profit, and potential share price.RWA could support innovative stablecoin creation or staking mechanisms, creating new financial opportunities for the company and shareholders. 

* Market Validation & Mission Impact TruLeaf's support is a vote of confidence from a successful, established partner.Accelerates growth, operational scaling, and market entry.Delivers meaningful impact for patients and the TXTM Tribe Mission: "raising all boats." 

Dylon Du Plooy, CEO, mentioned:

"This is a landmark moment for TXTM. TruLeaf's nanotechnology enhances our kettle technology, dramatically increasing bioavailability, making our products more effective, faster, and more affordable for patients. The resulting API is a real-world asset on our balance sheet, recognized as income/gain, and has the potential to support stablecoin creation for staking or investment — a transformative financial innovation. Combined with THC-free CBD FECO and Farm Bill compliance, we now have a regulatory and competitive advantage. This partnership accelerates growth, strengthens our market position, and aligns perfectly with the TXTM Tribe Mission: raising all boats, for shareholders, patients, and global healing."

**About Protext Mobility, Inc. (OTC: TXTM)**

Protext Mobility is focused on the research, testing, and development of highly bioavailable, nanotechnology-based botanical formulations for nutraceutical and pharmaceutical applications. Through proprietary live plant extraction technologies, the company aims to advance plant-based therapeutics that address wellness and health needs globally.

**Investor & Media Contact:**

Dylon Du Plooy – dylon@rsammd.co.za

Dr. J – exportintl@aol.com

**Follow Us:**

X (Twitter): https://x.com/ProtextP

**Forward-Looking Statements**

This press release contains forward-looking statements within the meaning of applicable securities laws. Actual results may differ materially due to market conditions, foreign exchange fluctuations, operational execution, regulatory requirements, and other risks detailed in the Company's filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements.